These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21958854)

  • 21. Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells.
    Wartlick H; Michaelis K; Balthasar S; Strebhardt K; Kreuter J; Langer K
    J Drug Target; 2004; 12(7):461-71. PubMed ID: 15621671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting HER2+ breast cancer cells: lysosomal accumulation of anti-HER2 antibodies is influenced by antibody binding site and conjugation to polymeric nanoparticles.
    Owen SC; Patel N; Logie J; Pan G; Persson H; Moffat J; Sidhu SS; Shoichet MS
    J Control Release; 2013 Dec; 172(2):395-404. PubMed ID: 23880472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of metal-chelating polymers (MCPs) for 111In complexed via the streptavidin-biotin system to trastuzumab Fab fragments on tumor and normal tissue distribution in mice.
    Boyle AJ; Liu P; Lu Y; Weinrich D; Scollard DA; Ngo Njock Mbong G; Winnik MA; Reilly RM
    Pharm Res; 2013 Jan; 30(1):104-16. PubMed ID: 22907419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell culture and xenograft-bearing animal studies of radiolabeled antisense DNA carrier nanoparticles with streptavidin as a linker.
    Nakamura K; Wang Y; Liu X; Kubo A; Hnatowich DJ
    J Nucl Med; 2007 Nov; 48(11):1845-52. PubMed ID: 17978353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multivalent interactions between biotin-polyrotaxane conjugates and streptavidin as a model of new targeting for transporters.
    Ooya T; Yui N
    J Control Release; 2002 Apr; 80(1-3):219-28. PubMed ID: 11943400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient delivery of streptavidin to mammalian cells: clathrin-mediated endocytosis regulated by a synthetic ligand.
    Hussey SL; Peterson BR
    J Am Chem Soc; 2002 Jun; 124(22):6265-73. PubMed ID: 12033853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological evaluation of a novel Herceptin-platinum (II) conjugate for efficient and cancer cell specific delivery.
    Huang R; Sun Y; Zhang XY; Sun BW; Wang QC; Zhu J
    Biomed Pharmacother; 2015 Jul; 73():116-22. PubMed ID: 26211591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug targeting to the brain using avidin-biotin technology in the mouse; (blood-brain barrier, monoclonal antibody, transferrin receptor, Alzheimer's disease).
    Jeong Lee H; Pardridge WM
    J Drug Target; 2000; 8(6):413-24. PubMed ID: 11328667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
    Casalini P; Luison E; Ménard S; Colnaghi MI; Paganelli G; Canevari S
    J Nucl Med; 1997 Sep; 38(9):1378-81. PubMed ID: 9293791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer.
    Mi Y; Zhao J; Feng SS
    J Control Release; 2013 Aug; 169(3):185-92. PubMed ID: 23403395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumor.
    Liu G; He J; Dou S; Gupta S; Rusckowski M; Hnatowich DJ
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1115-23. PubMed ID: 16133391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new application of plant virus nanoparticles as drug delivery in breast cancer.
    Esfandiari N; Arzanani MK; Soleimani M; Kohi-Habibi M; Svendsen WE
    Tumour Biol; 2016 Jan; 37(1):1229-36. PubMed ID: 26286831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A receptor-mediated gene delivery system using streptavidin and biotin-derivatized, pegylated epidermal growth factor.
    Lee H; Kim TH; Park TG
    J Control Release; 2002 Sep; 83(1):109-19. PubMed ID: 12220843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V.
    Cauchon N; Langlois R; Rousseau JA; Tessier G; Cadorette J; Lecomte R; Hunting DJ; Pavan RA; Zeisler SK; van Lier JE
    Eur J Nucl Med Mol Imaging; 2007 Feb; 34(2):247-58. PubMed ID: 17021816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-particle emitting atomic generator (Actinium-225)-labeled trastuzumab (herceptin) targeting of breast cancer spheroids: efficacy versus HER2/neu expression.
    Ballangrud AM; Yang WH; Palm S; Enmon R; Borchardt PE; Pellegrini VA; McDevitt MR; Scheinberg DA; Sgouros G
    Clin Cancer Res; 2004 Jul; 10(13):4489-97. PubMed ID: 15240541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved tumor targeting and decreased normal tissue accumulation through extracorporeal affinity adsorption in a two-step pretargeting strategy.
    Mårtensson L; Nilsson R; Ohlsson T; Sjögren HO; Strand SE; Tennvall J
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5572s-5576s. PubMed ID: 17875791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog.
    Liu G; Mang'era K; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
    J Nucl Med; 2002 Mar; 43(3):384-91. PubMed ID: 11884499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude mice.
    Lewis MR; Zhang J; Jia F; Owen NK; Cutler CS; Embree MF; Schultz J; Theodore LJ; Ketring AR; Jurisson SS; Axworthy DB
    Nucl Med Biol; 2004 Feb; 31(2):213-23. PubMed ID: 15013487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ¹¹¹In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer.
    Fasih A; Fonge H; Cai Z; Leyton JV; Tikhomirov I; Done SJ; Reilly RM
    Breast Cancer Res Treat; 2012 Aug; 135(1):189-200. PubMed ID: 22736376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoassay of total prostate-specific antigen using europium(III) nanoparticle labels and streptavidin-biotin technology.
    Huhtinen P; Soukka T; Lövgren T; Härmä H
    J Immunol Methods; 2004 Nov; 294(1-2):111-22. PubMed ID: 15604021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.